Development and preliminary clinical verification of an immune age model based on peripheral immune cells
Open Access
- 4 April 2026
- journal article
- Published by Elsevier in Immunobiology
- Vol. 231 (3) , 153179
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82472346)
- Natural Science Foundation of Sichuan Province (2024NSFSC1540)
- Natural Science Foundation of Sichuan Province (ZYAI24002)
- Sichuan University
- West China Hospital, Sichuan University
- National Key Research and Development Program of China (2022YFC2406600/2022YFC2406604)
This publication has 56 references indexed in Scilit:
- From infection to immune exhaustion: The Epstein-Barr virus and its contribution to ImmunosenescenceBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- Differences in the post-stroke innate immune response between young and oldSeminars in Immunopathology, 2023
- Meta-hallmarks of aging and cancerCell Metabolism, 2023
- Immunosenescence and inflamm-ageing in COVID-19Ageing Research Reviews, 2022
- Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging processAgeing Research Reviews, 2022
- Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?Ageing Research Reviews, 2021
- Immunology of Aging: the Birth of InflammagingClinical Reviews in Allergy & Immunology, 2021
- The interplay between immunosenescence and age-related diseasesSeminars in Immunopathology, 2020
- Age and gender leucocytes variances and references values generated using the standardized ONE‐Study protocolCytometry Part A, 2016
- The role of B lymphocytes in the progression from autoimmunity to autoimmune diseaseClinical Immunology, 2013